"The agreement [1] will provide every State Medicaid program in the country access to MFN drug prices on AstraZeneca products.... [2] guarantee[s] MFN prices on all new innovative medicines AstraZeneca brings to market.... [3] requires AstraZeneca to repatriate increased foreign revenue on existing products ... [4] requires AstraZeneca to offer medicines at a deep discount off the list price when selling directly to American patients."  MORE >>